Skip to main content

. 1992 May;55(5):413. doi: 10.1136/jnnp.55.5.413

Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.

N Turjanski, A J Lees

PMCID: PMC489093 PMID: 1602321

413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bergmann K. J., Limongi J. C., Lowe Y. H., Mendoza M. R., Yahr M. D. Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist. Lancet. 1984 Mar 10;1(8376):559–559. doi: 10.1016/s0140-6736(84)90947-4. [DOI] [PubMed] [Google Scholar]
Crossman A. R. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov Disord. 1990;5(2):100–108. doi: 10.1002/mds.870050203. [DOI] [PubMed] [Google Scholar]
Gaio J. M., Pollak P., Hommel M., Perret J. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia. J Neurol Neurosurg Psychiatry. 1987 Dec;50(12):1674–1678. doi: 10.1136/jnnp.50.12.1674. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES